What is Nabota Reconstitution Ratio?
Nabota is a purified botulinum toxin type A product that arrives as a vacuum‑dried powder in a 100 IU vial. Before injection the powder must be reconstituted with sterile 0.9 % sodium chloride (saline). The reconstitution ratio describes how many millilitres of saline are added to the vial, which directly determines the concentration of toxin in the final solution and influences dosage accuracy, spread, pain and cost‑per‑treatment.
Manufacturers typically recommend a specific volume of diluent, but many clinicians adjust the ratio based on clinical experience, the treatment area and desired diffusion characteristics. Below is a concise overview of the most common reconstitution practices, supported by clinical data and practical tips.
Typical Reconstitution Volumes and Resulting Concentrations
| Vial Size | Reconstitution Volume (ml) | Resulting Concentration (IU per 0.1 ml) | Typical Use Case |
|---|---|---|---|
| 100 IU | 2.5 ml | 4 IU | General facial lines – provides moderate diffusion. |
| 100 IU | 1.0 ml | 10 IU | Precision areas (e.g., crow’s feet) – limits spread. |
| 100 IU | 0.5 ml | 20 IU | Very small, deep injections – higher concentration, more pain. |
| 100 IU | 5.0 ml | 2 IU | Large surface areas (e.g., hyperhidrosis) – very low concentration, wide spread. |
These numbers assume the use of a 0.9 % saline solution. Switching to a different diluent (e.g., 0.5 % lidocaine) can slightly alter the pH and may affect toxin stability, although studies show no clinically significant loss of potency when lidocaine is used within the first 4 hours after reconstitution (Park et al., 2020).
Impact on Injection Volume and Dose per Site
The chosen reconstitution ratio determines how many units are delivered per millilitre, which translates into the volume you inject at each point. For example:
| Indication | Recommended Dose (IU) | Typical Injection Volume per Point (ml) – based on 2.5 ml reconstitution |
|---|---|---|
| Glabellar frown lines | 20 IU | 0.05 ml (≈ 2 IU) |
| Horizontal forehead lines | 10–20 IU | 0.05–0.1 ml |
| Crow’s feet (per side) | 12 IU | 0.05 ml |
| Axillary hyperhidrosis (per side) | 50 IU | 0.2–0.25 ml |
If you reconstitute with 1 ml instead, each 0.05 ml contains 5 IU, which reduces the total volume needed but can increase the sensation of pressure at the injection site because the solution is more viscous.
Clinical Evidence on Reconstitution Ratio
Several randomized trials have examined how different dilutions affect efficacy, duration and adverse‑event rates.
- A double‑blind study by Kim et al. (2021) compared 2.5 ml versus 1 ml reconstitution in 120 patients treated for glabellar lines. The authors reported a 12 % longer duration of effect and a 9 % lower incidence of mild bruising in the 2.5 ml group.
- Park et al. (2020) evaluated pain scores using a visual analogue scale (VAS). Patients receiving the 1 ml dilution reported VAS scores of 4.2 ± 1.1 versus 2.8 ± 1.0 for the 2.5 ml dilution (p < 0.05), indicating that higher concentrations can be more painful.
- A 2022 multicenter registry (Dorizas et al.) found that clinicians who used the 0.5 ml reconstitution for crow’s feet achieved a 15 % higher rate of complete elimination of lines at 4 weeks, but the rate of temporary eyelid ptosis increased from 1.2 % to 3.8 %.
“In our randomized trial, the 2.5 ml dilution provided a 12 % increase in duration of effect compared with 1 ml dilution.” — Kim et al., 2021
Factors to Consider When Choosing a Ratio
Selecting the optimal reconstitution volume is not a one‑size‑fits‑all decision. Practitioners often weigh the following variables:
- Patient age and skin thickness: Older patients with thinner skin may benefit from a lower concentration (more diluent) to avoid excessive diffusion.
- Treatment area: Dynamic wrinkles (forehead, glabella) often require moderate diffusion, while static lines or small muscles (e.g., orbicularis oculi) may need higher concentration for precision.
- Desired diffusion radius: Larger areas (hyperhidrosis, calf reduction) typically use a higher diluent volume to spread the toxin more evenly.
- Previous response to toxin: Patients who previously experienced ptosis may be switched to a more dilute preparation to reduce potency per unit volume.
- Pain tolerance: Higher concentrations correlate with increased injection discomfort; adding a small amount of lidocaine to the diluent can mitigate this without compromising potency.
Practical Step‑by‑Step Reconstitution Guide
- Chill the vial and saline to 2‑8 °C (optional but helps reduce foaming).
- Use a 21‑G needle to slowly inject the saline along the inner wall of the vial. Avoid vigorous shaking, which creates air bubbles.
- Swirl gently for about 30 seconds until the powder fully dissolves. The solution should appear clear and free of particulates.
- Allow the mixture to stand for 2–5 minutes to let any micro‑bubbles rise and dissipate.
- Withdraw the reconstituted toxin into a 1 ml insulin syringe or a 0.5 ml tuberculin syringe for precise dosing.
- Use a 30‑G needle for injection to minimize tissue trauma.
Stability and Storage After Reconstitution
Once reconstituted, Nabota maintains its potency for:
- 24 hours when stored at 2‑8 °C (refrigerated).
- 8 hours at room temperature (20‑25 °C).
Discard any unused solution after these timeframes, as the risk of bacterial contamination and loss of activity increases. Do not freeze the reconstituted product.
Cost‑Effectiveness: Dilution versus Number of Treatments
A 100 IU vial can be used for multiple patients depending on the chosen